Expression profile of microrna-145 in urothelial bladder cancer

Purpose Bladder cancer (BC) is the second most common malignancy of the urinary tract, with high mortality. The knowledge of the molecular pathways associated with BC carcinogenesis is crucial to identify new diagnostic and prognostic biomarkers. MicroRNAs (miRNAs) are short non-coding RNA molecules that play important roles in the regulation of gene expression by acting directly on mRNAs. miR-145 has been considered as a tumor suppressor, which targets the c-MYC, MUC-1 and FSCN1 genes. Our aim was to evaluate the expression profile of miR-145 in low-grade non-invasive and high-grade invasive bladder urothelial carcinomas. Materials and Methods We studied 30 specimens of low-grade, non-invasive pTa and 30 of pT2/pT3 high-grade invasive UC obtained by transurethral resection or radical cystectomy, followed over a mean time of 16.1 months. Normal controls were represented by five samples of normal bladder biopsy from patients who underwent retropubic prostatectomy to treat BPH. miRNA extraction and cDNA generation were performed using commercial kits. Analysis was performed by qRT-PCR, and miR-145 expression was calculated using the 2-∆∆ct method; we used RNU-43 and RNU-48 as endogenous controls. Results miR-145 was under-expressed in 73.3% and 86.7% of pTa and pT2/pT3, respectively, with expression means of 1.61 for the former and 0.66 for the last. There were no significant differences in miR-145 expression and histological grade, tumor stage, angiolymphatic neoplastic invasion and tumor recurrence. Conclusion miR-145 is under-expressed in low-grade, non-invasive and high-grade invasive urothelial bladder carcinoma and may play an important role in the carcinogenesis pathway, being an interesting candidate diagnostic marker.

Saved in:
Bibliographic Details
Main Authors: Dip,Nelson, Reis,Sabrina T., Srougi,Miguel, Dall'oglio,Marcos F., Leite,Katia R. M.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000100095
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382013000100095
record_format ojs
spelling oai:scielo:S1677-553820130001000952013-04-10Expression profile of microrna-145 in urothelial bladder cancerDip,NelsonReis,Sabrina T.Srougi,MiguelDall'oglio,Marcos F.Leite,Katia R. M. MicroRNAs MIRN145 microRNA, human [Supplementary Concept] Urinary Bladder Diagnostic Techniques, Urological Biological Markers Purpose Bladder cancer (BC) is the second most common malignancy of the urinary tract, with high mortality. The knowledge of the molecular pathways associated with BC carcinogenesis is crucial to identify new diagnostic and prognostic biomarkers. MicroRNAs (miRNAs) are short non-coding RNA molecules that play important roles in the regulation of gene expression by acting directly on mRNAs. miR-145 has been considered as a tumor suppressor, which targets the c-MYC, MUC-1 and FSCN1 genes. Our aim was to evaluate the expression profile of miR-145 in low-grade non-invasive and high-grade invasive bladder urothelial carcinomas. Materials and Methods We studied 30 specimens of low-grade, non-invasive pTa and 30 of pT2/pT3 high-grade invasive UC obtained by transurethral resection or radical cystectomy, followed over a mean time of 16.1 months. Normal controls were represented by five samples of normal bladder biopsy from patients who underwent retropubic prostatectomy to treat BPH. miRNA extraction and cDNA generation were performed using commercial kits. Analysis was performed by qRT-PCR, and miR-145 expression was calculated using the 2-∆∆ct method; we used RNU-43 and RNU-48 as endogenous controls. Results miR-145 was under-expressed in 73.3% and 86.7% of pTa and pT2/pT3, respectively, with expression means of 1.61 for the former and 0.66 for the last. There were no significant differences in miR-145 expression and histological grade, tumor stage, angiolymphatic neoplastic invasion and tumor recurrence. Conclusion miR-145 is under-expressed in low-grade, non-invasive and high-grade invasive urothelial bladder carcinoma and may play an important role in the carcinogenesis pathway, being an interesting candidate diagnostic marker. info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.39 n.1 20132013-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000100095en10.1590/S1677-5538.IBJU.2013.01.12
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Dip,Nelson
Reis,Sabrina T.
Srougi,Miguel
Dall'oglio,Marcos F.
Leite,Katia R. M.
spellingShingle Dip,Nelson
Reis,Sabrina T.
Srougi,Miguel
Dall'oglio,Marcos F.
Leite,Katia R. M.
Expression profile of microrna-145 in urothelial bladder cancer
author_facet Dip,Nelson
Reis,Sabrina T.
Srougi,Miguel
Dall'oglio,Marcos F.
Leite,Katia R. M.
author_sort Dip,Nelson
title Expression profile of microrna-145 in urothelial bladder cancer
title_short Expression profile of microrna-145 in urothelial bladder cancer
title_full Expression profile of microrna-145 in urothelial bladder cancer
title_fullStr Expression profile of microrna-145 in urothelial bladder cancer
title_full_unstemmed Expression profile of microrna-145 in urothelial bladder cancer
title_sort expression profile of microrna-145 in urothelial bladder cancer
description Purpose Bladder cancer (BC) is the second most common malignancy of the urinary tract, with high mortality. The knowledge of the molecular pathways associated with BC carcinogenesis is crucial to identify new diagnostic and prognostic biomarkers. MicroRNAs (miRNAs) are short non-coding RNA molecules that play important roles in the regulation of gene expression by acting directly on mRNAs. miR-145 has been considered as a tumor suppressor, which targets the c-MYC, MUC-1 and FSCN1 genes. Our aim was to evaluate the expression profile of miR-145 in low-grade non-invasive and high-grade invasive bladder urothelial carcinomas. Materials and Methods We studied 30 specimens of low-grade, non-invasive pTa and 30 of pT2/pT3 high-grade invasive UC obtained by transurethral resection or radical cystectomy, followed over a mean time of 16.1 months. Normal controls were represented by five samples of normal bladder biopsy from patients who underwent retropubic prostatectomy to treat BPH. miRNA extraction and cDNA generation were performed using commercial kits. Analysis was performed by qRT-PCR, and miR-145 expression was calculated using the 2-∆∆ct method; we used RNU-43 and RNU-48 as endogenous controls. Results miR-145 was under-expressed in 73.3% and 86.7% of pTa and pT2/pT3, respectively, with expression means of 1.61 for the former and 0.66 for the last. There were no significant differences in miR-145 expression and histological grade, tumor stage, angiolymphatic neoplastic invasion and tumor recurrence. Conclusion miR-145 is under-expressed in low-grade, non-invasive and high-grade invasive urothelial bladder carcinoma and may play an important role in the carcinogenesis pathway, being an interesting candidate diagnostic marker.
publisher Sociedade Brasileira de Urologia
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000100095
work_keys_str_mv AT dipnelson expressionprofileofmicrorna145inurothelialbladdercancer
AT reissabrinat expressionprofileofmicrorna145inurothelialbladdercancer
AT srougimiguel expressionprofileofmicrorna145inurothelialbladdercancer
AT dallogliomarcosf expressionprofileofmicrorna145inurothelialbladdercancer
AT leitekatiarm expressionprofileofmicrorna145inurothelialbladdercancer
_version_ 1756428129125007360